Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tolerance and pharmacokinetics studyof recombinant human thymosin beta4 (NL005) for single administration in Chinese healthy subjects

Next Previous
Trial Profile

Tolerance and pharmacokinetics studyof recombinant human thymosin beta4 (NL005) for single administration in Chinese healthy subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 18 Jul 2017

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top